COVID-19 Pathogenesisin the oral cavity: A Review on Oral Impairments and Manifestations
DOI:
https://doi.org/10.33295/1992-576X-2023-1-2-8Keywords:
coronavirus, oral cavity, lesions, mucosaAbstract
Abstract. With COVID-19, along with other organ systems, symptoms can also appear in the oral cavity. COVID-19 can cause a number of pathological conditions in the oral cavity of patients, candidiasis, xerostomia, recurrent herpetic lesions, ulcers, vesicles, desquamative gingivitis have been reported, the tongue, palate, lips, gums and buccal mucosa may be affected. Patients with COVID-19 may have difficulty swallowing, burning sensation, most patients have impaired taste and smell. However it is still impossible to draw a clear parallel between the manifestations of dental diseases and the severity of the coronavirus infection, since too little statistical data and clinical observations are available therefore needed for further investigation.
The goal of this revue was to compile a list of COVID-19 symptoms in oral tissues and analyze the potential etiopathogenesis that may influence the development of these oral lesions. The key terms were used to search international databases for information. A total of 50 sources on relevant topics were chosen.
These preliminary data explain the underlying mechanism oral lesions in Covid-19, and will help on future preventive strategies in clinical practice and in everyday life.
Downloads
References
Liu X, Liu C, Liu G, Luo W, Xia N. COVID-19: progress in diagnostics, therapy and vaccination. Theranostics 2020; 10 (17): 7821-35. doi: https://doi.org/10.7150/thno.47987 PMid:32685022 PMCid:PMC7359073
Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: the status and perspectives in delivery points of view. Adv Drug Deliv Rev 2021;170:1-25. doi: https://doi.org/10.1016/j.addr.2020.12.011 PMid:33359141 PMCid:PMC7759095
Pereira LJ, Pereira CV, Murata RM, Pardi V, Pereira-DouradoSM.Biological and social aspects of Coronavirus Disease 2019 (COVID-19) related to oral health.Braz Oral Res. 2020; 34:e041. https://doi.org/10.1590/1807-3107bor-2020.vol34.0041 PMid:32401931
Wang Y, Li X, Ren L, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 PMid:31986264
Xiang Z, Koo H, Chen Q, Zhou X, Liu Y, Simon-Soro A. Potentialimplications of SARS-CoV-2 oral infection in the host microbiota. J OralMicrobiol 2020; 13 (1): 1853451. doi: https://doi.org/10.1080/20002297.2020.1853451 PMid:33312449 PMCid:PMC7711743
Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021;19(3):141-54. doi: https://doi.org/10.1038/s41579-020-00459-7 PMid:33024307 PMCid:PMC7537588
Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250-6. doi: https://doi.org/10.1002/jmv.26232 PMid:32592501 PMCid:PMC7361342
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC.Pathophysiology, transmission, diagnosis, and treatment of coronavirusdisease 2019 (COVID-19): a review. JAMA 2020;324(8):782-93. doi: https://doi.org/10.1001/jama.2020.12839 PMid:32648899
Mahyuddin AP, Kanneganti A, Wong J, Dimri PS, Su LL, Biswas A, Illanes SE, Mattar C, Huang RJ, Choolani M. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV -2. Prenat. Diagn2020; 40(13):1655-1670. doi: https://doi.org/10.1002/pd.5765 PMid:32529643 PMCid:PMC7307070
Matsuyama S, Ujike M, Morikawa S, Tashiro M, Taguchi F. Protease-mediated enhancement of severeacute respiratory syndrome coronavirus infection. Proc. Natl. Acad. Sci. USA 2005; 102(35):12543-12547. doi: https://doi.org/10.1073/pnas.0503203102 PMid:16116101 PMCid:PMC1194915
Song H, Seddighzadeh B, Cooperberg MR, Huang FW. Expression of ACE2, the SARS-CoV-2 Receptor and TMPRSS2 in Prostate Epithelial Cells. Eur. Urol. 2020; 78(2):296-298.doi: https://doi.org/10.1016/j.eururo.2020.04.065 PMid:32418620 PMCid:PMC7200365
Kawase M, Shirato K, Van Der Hoek L, Taguchi F, Matsuyama S. Simultaneous Treatment of HumanBronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute RespiratorySyndrome Coronavirus Entry. J. Virol. 2012; 86(12):6537-6545. doi: https://doi.org/10.1128/JVI.00094-12 PMid:22496216 PMCid:PMC3393535
Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, Bolling MC, Dijkstra G, Voors AA, Osterhaus AD et al. Angiotensinconverting enzyme 2 (ACE2), SARS-CoV-2 andthe pathophysiology of coronavirus disease 2019 (COVID-19). J. Pathol. 2020; 251 (3): 228-248. doi: https://doi.org/10.1002/path.5471 PMid:32418199 PMCid:PMC7276767
Darbani B. The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: JuxtaposingPopulation Groups, Gender, and Di_erent Tissues. Int. J. Environ. Res. Public Heal. 2020; 17(10):3433. doi: https://doi.org/10.3390/ijerph17103433 PMid:32423095 PMCid:PMC7277542
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N et al. Genomiccharacterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptorbinding. Lancet 2020; 395(10224):565-574. doi: https://doi.org/10.1016/S0140-6736(20)30251-8 PMid:32007145
Wang WK, Chen SY, I-Jung Liu IJ, Chen YC, Chen HL, Chao-Fu Yang CF, Chen PJ, Yeh SH, Kao CH, Huang LM et al. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg. Infect. Dis. 2004; 10 (7): 1213-1219. doi: https://doi.org/10.3201/eid1007.031113 PMid:15324540 PMCid:PMC3323313
Boöttcher E, Matrosovich T, Beyerle M, Klenk H.-D, Garten W, Matrosovich M. Proteolytic Activationof Influenza Viruses by Serine Proteases TMPRSS2 and HAT from Human Airway Epithelium. J. Virol. 2006;80(19):9896-9898. doi: https://doi.org/10.1128/JVI.01118-06 PMid:16973594 PMCid:PMC1617224
Tanabe LM, List K. The role of type II transmembrane serine protease-mediated signaling in cancer. FEBS J.2017; 284 (10): 1421-1436. doi: https://doi.org/10.1111/febs.13971 PMid:27870503 PMCid:PMC5432387
Collin J, Queen R, Zerti D, Dorgau B, Georgiou M, Djidrovski I, Hussain R, Coxhead JM, Joseph A, Rooney P et al. Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival,limbal and corneal epithelium suggests an additional route of entry via the ocular surface. Ocul. Surf. 2021; 19: 190-200. doi: https://doi.org/10.1016/j.jtos.2020.05.013 PMid:32502616 PMCid:PMC7267807
Carreras-Presas CM, Sбnchez JA, Lуpez-Sбnchez AF, Janй-Salas E, Pйrez MLS. Oral vesiculobullouslesions associated with SARS-CoV-2 infection. Oral Dis. 2021; 3: 710-712. doi: https://doi.org/10.1111/odi.13382 PMid:32369674 PMCid:PMC7267423
Hasan A, Paray BA, Hussain A, Qadir FA, Attar F Aziz FM, Sharifi M, Derakhshankhah H, Rasti B, Mehrabi M et al. A review on the cleavage priming of the spike protein on coronavirus byangiotensin-converting enzyme-2 and furin. J BiomolStructDyn. 2021; 39 (8): 3025-3033. doi: https://doi.org/10.1080/07391102.2020.1754293 PMid:32274964 PMCid:PMC7189411
Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of thenew coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020; 176:104742. doi: https://doi.org/10.1016/j.antiviral.2020.104742 PMid:32057769 PMCid:PMC7114094
Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing andscaling in individuals with periodontal inflammation. J. Clin. Periodontol. 2006; 33(6):401-407. doi: https://doi.org/10.1111/j.1600-051X.2006.00924.x PMid:16677328
Hamming I, Timens W, Bulthuis M, Lely AT, Navis G, Van Goor H. Tissue distribution of ACE2protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.J. Pathol. 2004; 203(2):631-637. doi: https://doi.org/10.1002/path.1570 PMid:15141377 PMCid:PMC7167720
Li Y, Zhou W, Yang L, You R. Physiological and pathological regulation of ACE2, the SARS-CoV-2receptor. Pharmacol. Res. 2020; 157:104833. doi: https://doi.org/10.1016/j.phrs.2020.104833 PMid:32302706 PMCid:PMC7194807
Wysocki J, Garcia-Halpin L, Ye M, Maier C, Sowers K, Burns KD, Batlle D. Regulation of urinaryACE2 in diabetic mice. Am. J. Physiol. Physiol. 2013; 305(4): F600-F611. doi: https://doi.org/10.1152/ajprenal.00600.2012 PMid:23761674 PMCid:PMC3891267
Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X. Nicotine and the renin-angiotensin system.Am. J. Physiol. Integr. Comp. Physiol. 2018; 315(5):R895-R906. doi: https://doi.org/10.1152/ajpregu.00099.2018 PMid:30088946 PMCid:PMC6295500
Tu Y-P, Jennings R, Hart B, Cangelosi GA, Wood RC, Wehber K, Verma P, Vojta D, Berke EM.Swabs Collected by Patients or Health CareWorkers for SARS-CoV-2 Testing. New Engl. J. Med. 2020;383(5):494-496. doi: https://doi.org/10.1056/NEJMc2016321 PMid:32492294 PMCid:PMC7289274
Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, CurrieM, Lisy K, Qureshi R, Mattis P, Mu P-F. Chapter 7: Systematic reviews ofetiology and risk. Aromataris E, Munn Z (Editors) JBI Man Evid SynthJBI, 2017. Available from https://reviewersmanual.joannabriggs.org/
Cuevas-Gonzalez MV, Espinosa-Cristуbal LF, Donohue-Cornejo A, Karla Lizette Tovar-Carrillo KL, Saucedo-Acuсa RA, Garcнa-Calderуn AG, Guzmбn-Gastelum DA, Cuevas-Gonzalez JC. COVID-19 and its manifestations in the oral cavity: A systematic review. Medicine 2021;100(51):e28327. doi: https://doi.org/10.1097/MD.0000000000028327 PMid:34941133 PMCid:PMC8701462
Brandão TB, Gueiros LA, Melo TS et al. Oral lesions in patients withSARS-CoV-2 infection: could the oral cavity be a target organ? Oral SurgOral Med Oral Pathol Oral Radiol 2021;131(2):e45-51. doi: 10.1016/j.oooo.2020.07.014 https://doi.org/10.1016/j.oooo.2020.07.014 PMid:32888876 PMCid:PMC7434495
Carreras-Presas MC, Amaro Sánchez J, López-Sánchez AF, Jané-Salas E, Somacarrera Pérez ML. Oral vesiculobullous lesions associatedwith SARS-CoV-2 infection. Oral Dis 2021; 27 Suppl 3: 710-2. doi: https://doi.org/10.1111/odi.13382 PMid:32369674 PMCid:PMC7267423
Rodrнguez DM, Jimenez Romera A, Villarroel M. Oral manifestationsassociated with COVID-19. Oral Dis 2020;10.1111/odi.13555. doi: 10.1111/odi.13555. Online ahead of print. https://doi.org/10.1111/odi.13555 PMid:32697005 PMCid:PMC7404436
Mahmoud MM, Abuohashish HM, Khairy DA, Bugshan AS, Khan AM, Moothedath MM. Pathogenesis of dysgeusia in COVID-19 patients: a scoping review. Eur Rev Med PharmacolSci 2021; 25 (2): 1114-34. doi: 10.26355/eurrev_202101_24683
Sakaguchi W, Kubota N, Shimizu T et al. Existence of SARS-CoV-2entry molecules in the oral cavity. Int J MolSci 2020; 21 (17): 6000. doi: https://doi.org/10.3390/ijms21176000 PMid:32825469 PMCid:PMC7503451
Kitakawa D, Oliveira FE, Neves De Castro P, Carvalho LFCS. Shortreport - Herpes simplex lesion in the lip semimucosa in a COVID-19 patient. Eur Rev Med PharmacolSci 2020; 24 (17): 9151-3. doi: https://doi.org/10.26355/eurrev_202009_22863
Villarroel-Dorrego M, Chac'on L, Rosas R, Barrios V, Pern'ıa Y, V'elez H. Oral Findings in Patients With COVID-19.2021; S1578- 2190(21):00333-4. doi: https://doi.org/10.1016/j.adengl.2021.11.028 PMid:34848890 PMCid:PMC8619883
Jimenez-Cauhe J, Ortega-Quijano D, de Perosanz-Lobo D, Burgos-Blasco P, Vaсó-Galván S, Fernandez-Guarino M, Fernandez-Nieto D.Enanthem in Patients With COVID-19 and Skin Rash. JAMA Dermatol. 2020; 156 (10): 1134-1136. doi: https://doi.org/10.1001/jamadermatol.2020.2550 PMid:32667631 PMCid:PMC7364334
Kahraman CF, Çaşkurlu H. Mucosal involvement in a COVID-19-positive patient: A case report. DermatolTher. 2020;33(4):e13797. doi: https://doi.org/10.1111/dth.13797 PMCid:PMC7300528
Hocková B, Riad A, Valky J, Šulajová Z, Stebel A, Slávik R, Bečková Z, Pokorná A, Klugarová J, Klugar M. Oral Complications of ICU Patientswith COVID-19: Case-Series and Review of Two Hundred Ten Cases. J Clin Med. 2021; 10 (4): 581. doi: https://doi.org/10.3390/jcm10040581 PMid:33557130 PMCid:PMC7913822
Galvan Casas C, Catala A, Carretero Hernandez G, Rodriguez-Jimenez P,Fernandez-Nieto D, Rodriguez-Villa Lario A, Navarro Fernandez I,Ruiz-Villaverde R, Falkenhain-Lopez D, Llamas Velasco M, et al. Classification of the cutaneous manifestations of COVID-19: a rapidprospective nationwide consensus study in Spain with 375 cases. Br JDermatol. 2020; 183 (1): 71-77. doi: https://doi.org/10.1111/bjd.19163 PMid:32348545 PMCid:PMC7267236
Cox MJ, Loman N, Bogaert D, O'Grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020; 1 (1): e11. doi: https://doi.org/10.1016/S2666-5247(20)30009-4 PMid:32835323
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, WeiY et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet. 2020; 395 (10223) :507-513. doi: https://doi.org/10.1016/S0140-6736(20)30211-7 PMid:32007143
Amorim Dos Santos J, Normando AGC, Carvalho da Silva RL, De Paula RM, Cembranel AC, Santos-Silva AR, Guerra ENS. Oral mucosallesions in a COVID-19 patient: New signs or secondary manifestations? Int J Infect Dis. 2020; 97: 326-328. doi: https://doi.org/10.1016/j.ijid.2020.06.012 PMid:32526392 PMCid:PMC7280113
Farid H, Khan M, Jamal S, Ghafoor R.Oral manifestations of Covid-19-A literature review.Rev Med Virol. 2022;32(1):e2248. doi: https://doi.org/10.1002/rmv.2248 PMid:34028129 PMCid:PMC8209937
Kusiak A, Cichońska D, Tubaja M, et al. COVID-19 manifestation in the oral cavity - a narrative literature review. ActaOtorhinolaryngol Ital. 2021; 41 (5): 395-400. doi: https://doi.org/10.14639/0392-100X-N1584 PMid:34734574 PMCid:PMC8569657
Biadsee A, Biadsee A, Kassem F, et al. . Olfactory and oral manifestations of covid-19: sex-related symptoms - a potential pathway to early diagnosis. Otolaryngol Head Neck Surg. 2020; 163: 722-728. https://doi.org/10.1177/0194599820934380 PMid:32539587 PMCid:PMC7298562
Marouf N, Cai W, Said KN, et al. Association between periodontitis and severity of COVID-19 infection: a case-control study. J ClinPeriodontol. 2021; 48: 483-491. https://doi.org/10.1111/jcpe.13435 10.1111/jcpe.13435
https://doi.org/10.1111/jcpe.13435 PMid:33527378 PMCid:PMC8014679
Maheswaran T, Abikshyeet P, Sitra G, Gokulanathan S, Vaithiyanadane V, Jeelani S. Gustatory dysfunction. J Pharm Bioallied Sci. 6 Suppl. 2014; 6 (Suppl 1): S30-3. doi: https://doi.org/10.4103/0975-7406.137257 PMid:25210380 PMCid:PMC4157276
Vieira LA, Salzano G, Fois AG, Piombino P, De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020; 10 (9): 1103-1104. doi: https://doi.org/10.1002/alr.22593 PMid:32342636 PMCid:PMC7267531
Downloads
Published
How to Cite
Issue
Section
